Kathryn M. Johnson

Identification and Validation of the Mitochondrial F1F0-ATPase as the Molecular Target of the Immunomodulatory Benzodiazepine Bz-423

Kathryn M. Johnson, Xueni Chen, Anthony E. Boitano et al. · Chemistry & Biology · 2005 · 129 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +11

Benzodiazepine-induced superoxide signalsB cell apoptosis: mechanistic insight and potential therapeutic utility

Neal B. Blatt, Jeffrey J. Bednarski, Roscoe E. Warner et al. · Journal of Clinical Investigation · 2002 · 64 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

Benzodiazepine-induced superoxide signalsB cell apoptosis: mechanistic insight and potential therapeutic utility

Neal B. Blatt, Jeffrey J. Bednarski, Roscoe E. Warner et al. · Journal of Clinical Investigation · 2002 · 59 citations

Life Sciences, Cell Biology, Pharmacology +17

Inhibition of the mitochondrial F1F0-ATPase by ligands of the peripheral benzodiazepine receptor

Joanne Cleary, Kathryn M. Johnson, Anthony W. Opipari et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 54 citations

Life Sciences, Neuroscience, Pharmacology +13

Parallel Synthesis of Glycomimetic Libraries:  Targeting a C-Type Lectin

Michael C. Schuster, David A. Mann, Tonia J. Buchholz et al. · Organic Letters · 2003 · 42 citations

Pharmacy, Biochemistry, Medicinal Chemistry +14